AUA 2018 Prostate Cancer

REVIEW UroToday

Viewing 1-20 of 109 articles

AUA 2018: Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment Naïve Castration-Sensitive Metastatic Prostate Cancer

AUA 2018: Is PSA Density Useful in Predicting Low-Risk Prostate Cancer in African American Men?

AUA 2018: The More You See, The More You Miss: Association Between PI-RADS Score of the Index Lesion and Multi-Focal, Clinically Significant Prostate Cancer

AUA 2018: Multi-Institutional External Validation of the EAU Guidelines for the Use of Staging mpMRI Prior to Radical Prostatectomy in Men with Intermediate and High-Risk Prostate Cancer

AUA 2018: Association of Systematic Biopsy vs. Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsy with Prostate Cancer Upstaging at Radical Prostatectomy

AUA 2018: Evaluation of Gallium-68 PSMA PET/CT Imaging in Individuals with Biochemical Recurrence Following Radical Prostatectomy

AUA 2018: Local Immune Modulation by Decreasing CD4+/CD8+ T Cells Ratio after Prostate Cancer Hemi-Cryoablation

AUA 2018: ADT Increased the Risk of Pulmonary Embolism in Patients with Prostate Cancer - Taiwan National Health Insurance Research Database

AUA 2018: Association of Dose Reduction of Abiraterone Acetate plus Prednisone or Enzalutamide and PSA Progression in Veterans with mCRPC

AUA 2018: Impact of Lymph Node Count and Adjuvant Therapy on Oncologic Outcomes in Node Positive Patients with Prostate Cancer

AUA 2018: Prospective Evaluation of Effect on Intraocular Pressure and Visual Function in Patients Without and with Ophthalmic Diseases after Robotic Assisted Laparoscopic Prostatectomy

AUA 2018: Which Patients with Low Risk Prostate Cancer Are Still Receiving Radical Prostatectomy? Impact of Patient Selection on Inverse Stage Migration

AUA 2018: High Intensity Focused Ultrasound Dose Escalation Leads to Fewer Recurrences in Following Focal HIFU in Prostate Cancer

AUA 2018: PSA 1.5 is the new 4.0

AUA 2018: Prostate Biopsy Centralization at High Volume, Tertiary Care Centers Represents the Most Refined Diagnostic Tool for Prostate Cancer Patients

AUA 2018: The German Risk-Adapted Prostate Cancer Screening Trial (PROBASE) – First Results After Recruitment of 30,000 Men

AUA 2018: The Association Between Physician Trust and Prostate Specific Antigen Screening: Implications for Shared Decision Making

AUA 2018: PROSPER Study Results: Impact of Enzalutamide on Pain and Health-Related Quality of Life in Men with nmCRCP

AUA 2018: Cardiovascular Events and Biomarkers in a Randomized Trial Comparing LHRH Agonist and Antagonist Among Patients with Advanced Prostate Cancer

AUA 2018: The Effectiveness and Safety of Cabazitaxel in Patients with mCRPC in Routine Clinical Practice: Results of CAPRISTANA

1
2
3
4
5
6